Cancer Australia has engaged ORIMA Research to deliver the fourth national audit of cancer research funding and key funding drivers report, by undertaking an audit of cancer research funding across the period of 2021-2023 combined with a desktop review and analysis of the key drivers for cancer research patterns and funding over this period.

A later observation replaced this one. The explorer’s totals use $190,784.00 from the latest observation, published 7 July 2026.

$181,984.00

Full reported contract value · AUD including applicable GST · 2026-03-03 to 2026-08-14

Reporting agency: Cancer Australia
Reported supplier: ORIMA Research Pty Ltd
Reported ABN: 77 076 347 914. Exemption as supplied: No.
Category: Research programs
Procurement method: Open tender
Original publication: 2026-03-23 14:50:00 (ACT local time as supplied)
Amendment publication: Original notice; no amendment publication supplied
Amendment reason: Not supplied
Agency reference: PO1471
Approach to market / standing offer: ATM not supplied / SON3352211
Consultancy: No
Confidentiality as reported: Contract: No; outputs: No
Source observation: CN4227279 · Official weekly workbook ending 2026-03-28 · sheet “Contract Notice Export”, row 565.

The original register may now show later corrections. The card and this observation keep the saved source date.